Open access
Aug 2026
Mendelian randomization and drug repurposing analysis identifies APOE as a potential therapeutic target for low back pain
Mendelian randomization identified Apolipoprotein E (APOE) as causally protective against LBP and pharmacological modulation of APOE via glucocorticoids, cytokine antagonists, or PPARγ agonists represents a novel strategy for early intervention in disc degeneration.
Jian-Ye Yang, Wei-Hui Qi, Dong Wang et al.
· Medicine · 0 citations